The most comprehensive genetic analysis available, identifying the widest range of genetic variants that may contribute to genetic disorders. Provides maximum insight into potential genetic changes, enabling more accurate diagnostics and personalized treatment strategies.

Types of genetic alterations determined by whole genome sequencing:

• Single-nucleotide and multinucleotide variants (SNVs and MNVs)
• Small insertion-deletions (in/del) of up to 50 nucleotide pairs
• Gene copy number variations (CNVs) such as deletions/microdeletions and duplications/microduplications of various sizes
• Sites of loss of heterozygosity and uniparental disomy
• Variants in mitochondrial genome with >5% heteroplasmy detection
• Balanced chromosomal changes with breakpoint detection (with restrictions)
• Expansion of tandem repeats in 37 genes (with limitations)

Unlike other studies, WGS determines the presence ofall variants not only in coding regions of the genome (exons) but also in non-coding regions (introns, non-translated regions, intergenic regions), which account for up to 5% of pathogenic genetic variants.

We provide comprehensive exome sequencing to determine the structure of all coding regions (exons) across the genome.
Our study includes both clinically significant genes and all other human genes, offering detailed insights into genetic variations that may impact health and disease.

Types of genetic alterations determined by whole exome sequencing:

• Single-nucleotide and multinucleotide variants (SNVs and MNVs) in exons of all genes;
• Small insertion-deletions (in/del) of up to 50 nucleotide pairs
• Gene copy number variations (CNVs) such as deletions/microdeletions and medium to large size duplications/microduplications (fringing).

With whole exome sequencing, our clients gain access to a comprehensive genomic analysis that empowers researchers, clinicians, and healthcare professionals to better understand the complexities of human genetics, advancing personalized medicine and targeted therapeutic strategies.

We provide unlimited sequencing services to external researchers, delivering precision and innovation for their projects

Next Generation Frequencing

With the comprehensive suite of NGS solutions, we empower researchers across multiple fields, from clinical genomics to agriculture and beyond. Our NGS services include Targeted Sequencing/Panels (TCS), RNA sequencing and Spatial transcriptomics, Single-cell sequencing, Metagenomics, Epigenomics, Agrigenomics, Genotyping by sequencing (GBS) services for SNP discovery, ChIP-Seq, Amplicon Sequencing, MethylSeq.
We also provide the service of Next Generation Sequencing Library Preparation which includes the libraries for various tests: Whole Genome Sequencing, Exome Sequencing, Targeted Sequencing, Amplicon Sequencing, RNA Sequencing, Deseases focused on panels, and more.

This analysis is an ideal technique for genotyping and gene expression for multiple species

Microarray Analysis

Sanger Sequencing
and Fragment Analysis

Other
Services

Read more

Read more

The data included in our reports for every sequence are Phred20 analysis, *.ABI and *.scf trace files and seq files in text format. Verification sequencing reports provide the following: insertions, deletions, mismatches between reference sequence and sequencing data, and alignment between reference sequence and sequencing data.

Sanger Sequencing and Fragment Analysis

Sanger sequencing is used to study a small subset of genes linked to a defined phenotype, confirm next-generation sequencing (NGS) variants, detect minor allele fractions down to 5%, or read contiguous sequences up to 1,000 bases.

Fragment analysis is a powerful technique with simple, straightforward workflows and is used in a wide-range of applications, such as detection of mutations, genotyping, identification of short tandem repeats, and gene expression profiling.
We use Applied Biosystems genetic analysis systems - a trusted standard for Sanger sequencing and fragment analysis by capillary electrophoresis.

Other Services

We offer sequencing as a service to external researchers, providing access to our cutting-edge technologies on an unlimited basis. Whether for small-scale projects or high-throughput studies, our comprehensive services enable precise and reliable sequencing results.

Our life science laboratory services offer international reach, utilizing cutting-edge technologies and methodologies to ensure the most accurate and reliable results. Our expert staff, trained to the highest standards, has deep knowledge of both their fields and your business needs. We bring extensive experience in navigating both international and local regulations, providing tailored solutions for a wide range of industries.

Non Invasive prenatal testing

WGS, WES and targeted sequencing for diagnostics

Read more

Read more

Panorama test, NATERA, USA

NIFTY test, BGI, China

Non Invasive prenatal testing

Panorama is a blood-based genetic test for pregnant women that screens for common chromosomal conditions affecting a baby’s health.
Utilizing advanced SNP-based technology, it offers highly accurate non-invasive prenatal testing. The test can be performed as early as nine weeks gestation, with most results returned to your doctor within 5-7 calendar days.

NIFTY is a highly accurate, non-invasive prenatal screening test that uses a blood sample from the pregnant mother to detect chromosomal abnormalities in the fetus. Available from the 10th week of pregnancy, NIFTY screens for conditions like Down Syndrome (Trisomy 21) and Edwards Syndrome (Trisomy 18), among others, in both singleton and twin pregnancies. This test provides valuable insights into the health of the baby with minimal risk to the mother.

We offer highly accurate and widely recognized non-invasive prenatal testing (NIPT). This advanced testing method allows for the early detection of potential genetic conditions in the fetus with minimal risk to both mother and baby.

TESTS

PANELS

SERVICES

FREQUENTLY ORDERED

Panels

Cardiology

Whole Exome Family Plus

Expansion services

Whole Exome Sequencing

Dermatology

My Retina Tracker Program Panel

Customization if Diagnostic Panels

Single Gene Tests

Ear, Nose & Throat

Retina Dystrophy Panel

Re-evaluation and Re-analysis Service

Hematology

Comprehensive Epilepsy Panel

Malformations

Familial Variant Testing

Variant Specific Testing

Endocrinology

Aorta Panel

Clinical Genetics Support

Hereditary Cancer

Hypertrophic Cardiomyopathy (HCM) Panel

Metabolic Disirders

Neurology

What to Order?

Gastroenterology

Cardiomyopathy Panel

Immunology

Primary Immunodeficiency (PID) and Primary Ciliary Dyskinesia (PCD) Panel

Mitochondrial Disorders

Ophthalmology

Nephrology

Pulmonology

WGS, WES and targeted sequencing for diagnostics

Sequencing, data analysis, varialt calling, ACMG classification and clinical interpretation tailored to patient's phenotype

Preimplantation genetic testing

Molecular karyotyping

Read more

Read more

Molecular karyotyping

Our innovative oligonucleotide-based microarrays are specifically designed, developed, and validated by cytogeneticists and for cytogenticists performing molecular karyotyping. These advanced solutions enhance the accuracy and efficiency of chromosome anomaly characterization, making them invaluable for cytogenetic research and diagnostics.

Molecular cytogenetics is essential for characterizing chromosome anomalies and is critical in genetic research, including constitutional disorders and cancer studies. Sesana is advancing cytogenetic laboratories by introducing innovative methodologies that enhance diagnostic and research capabilities. Our innovative methodologies support:

Cancer profiling

Other tests

Read more

Read more

At Sesana, we are committed to helping you identify the optimal treatment path by utilizing the appropriate tests. This approach ensures the best possible outcomes based on the most relevant data, allowing for informed decision-making in patient care.

Cancer profiling

Other tests

SESANA offers a broad range of genetic and other tests across various clinical areas.

About SESANA company

SESANA is based in Hong Kong, with subsidiaries in Australia (Adoradum Genomics) and Kazakhstan (Genomed). We operate in rapidly growing Asian markets, including Kazakhstan, Uzbekistan, Kyrgyzstan, Mongolia, Tajikistan, Georgia, Turkmenistan, Philippines, Indonesia, Malaysia, Vietnam, Thailand and others, serving over 700 million population who produce a wealth of commodities and services. Our mission is to bring modern molecular and genetic technologies to these regions.

Adoradum Genomics offers expert support and guidance in selecting equipment and reagents, as well as implementing and maintaining methods and technologies.

Clients benefit from advice from specialists with practical experience in the equipment we provide. Representing a variety of leading Life Science brands, we offer a complete cycle of scientific research services, from DNA extraction to bioinformatics analysis.

GenoMed, Kazakhstan features a distribution division, production of scientific and medical products, along with a service and clinical laboratory.
Leveraging our expertise in molecular biology, sequencing, microarray analysis, and more, we provide comprehensieve solutions that extend beyond equipment sales, ensuring the clients receive the support and resources necessary for advanced scientific research and healthcare applications.

REASONABLE PRICING

HIGHLY QUALIFIED TEAM

We offer our products at competitive prices and are committed to fostering long-term cooperation and loyal partnerships by providing even more favorable pricing options for our clients.

In collaboration with industry leaders, we provde over 100 comprehensive laboratory services tailored for research projects.